Posted on 01/23/2022 4:25:43 AM PST by ransomnote
A rare spinal cord condition could be amongst the vaccine’s adverse side effects, according to an EU drug regulatory authority. The committee even, who reviewed the data over a three day conference, made a suggestion addressing vaccine manufacturers to add a warning and spread awareness.
A change to the product information has been indicated by the European Union’s drug regulator, for COVID-19 vaccines from AstraZeneca and Johnson & Johnson, recommends to include a warning of a rare spinal cord condition called transverse myelitis.
Transverse Myelitis is a rare condition that involves inflammation of one or both sides of the spinal cord. Symptoms can include tingling and weakness in the limbs, pain or numbness, loss of pain sensation, or issues with bowel and bladder function.
The change was recommended by Pharmacovigilance and Risk Assessment Committee (PRAC), the European Medicines Agency’s (EMA) committee that assesses the safety of human medicines, on Jan. 14 after concluding that a causal link between the two vaccines and TM is “at least a reasonable possibility.”
It recommends changing the product information for the COVID-19 shots — Johnson & Johnson’s Janssen and AstraZeneca’s Vaxzevria – to include a warning of “very rare cases of transverse myelitis (TM) reported following vaccination.” TM will also be added as an adverse reaction with an unknown frequency to the vaccine profile.
The committee reviewed the information on globally reported cases for both vaccines, including information from the European database for suspected vaccine side effects as well as data from the scientific literature, over three days of meetings.
The PRAC said it considered that a total of 38 TM cases were reported globally—25 with Vaxzevria, 13 with Janssen. “These numbers refer to suspected and not adjudicated cases of TM.” This is out of 33,584,049 doses for Janssen and 1.391 billion doses for Vaxzevria that have been estimated to have been administered globally, it said.
“Health care professionals should be alert to signs and symptoms of TM, allowing early diagnosis, supportive care, and treatment,” the EMA announced. “People receiving either of these vaccines are advised to seek immediate medical attention if they develop symptoms of the condition.”
MORE AT LINK
ransomnote: I just paused to search VAERS for Transverse Myelitus. Here are the reports published to VAERS for Covid 'vaccines'. Note that only a small proportion of such complications are ever reported to the CDC, so the numbers in the table below likely represent a tip of the iceberg (e.g., perhaps 1/100 of actual events).
Search VAERS Database (medalerts.org)
3.871e-5% for J&J.
that’s 0.00003871%
This is based entirely on the numbers in the article.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.